STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH (EIN 95-4002032)
Tax period
2016-04-01 to 2017-03-31
Filed
2017-08-11
IRS object ID
201722239349301927
Schema version
2016v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-08-11T17:00:31-05:00ReturnTs
Tax Period End2017-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN910189318PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Moss Adams LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1805 SW Broadway Ste 1200AddressLine1Txt
CityPortlandCityNm
State AbbreviationORStateAbbreviationCd
ZIP97205ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN954002032EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Alfred E Mann Foundation forBusinessNameLine1Txt
Business Name Line2Scientific ResearchBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlALFRBusinessNameControlTxt
Phone6617026700PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 Rye Canyon LoopAddressLine1Txt
CitySanta ClaritaCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJohn PetrovichPersonNm
Person TitleChief Executive Officer (Acting)PersonTitleTxt
Phone6617026700PhoneNum
Signature2017-08-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonWendy CamposPreparerPersonNm
PTINP00448102PTIN
Phone5032421447PhoneNum
Preparation2017-08-10PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address23.243.54.222IPv4AddressTxt
FieldValueIRS element (for citing)
IP2017-08-11IPDt
IP Tm16:48:44IPTm
IP TimezonePDIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdDA39A3EE5E6B4B0D3255BFEF95601890AFD80709AtSubmissionCreationDeviceId
At Submission Filing Device Id7D0D6C7A6A5655B0595BBDB8C4257A6B648F0CEBAtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJohn PetrovichPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 Rye Canyon LoopAddressLine1Txt
CitySanta ClaritaCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$34,851,877GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.aemf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1985FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionCONDUCT MEDICAL AND SCIENTIFIC RESEARCHActivityOrMissionDesc
Voting Members Governing Body3VotingMembersGoverningBodyCnt
Voting Members Independent3VotingMembersIndependentCnt
Total Employee80TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$76,035TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$75,375NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,124,238PYContributionsGrantsAmt
CY Contributions Grants$5,865CYContributionsGrantsAmt
PY Program Service Revenue$926,616PYProgramServiceRevenueAmt
CY Program Service Revenue$23,845CYProgramServiceRevenueAmt
PY Investment Income$2,867,141PYInvestmentIncomeAmt
CY Investment Income$953,967CYInvestmentIncomeAmt
PY Other Revenue-$377,460PYOtherRevenueAmt
CY Other Revenue$3,000CYOtherRevenueAmt
PY Total Revenue$4,540,535PYTotalRevenueAmt
CY Total Revenue$986,677CYTotalRevenueAmt
PY Grants And Similar Paid$7,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$8,000CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,867,512PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$9,596,695CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$2,044CYTotalFundraisingExpenseAmt
PY Other Expenses$6,378,698PYOtherExpensesAmt
CY Other Expenses$5,741,212CYOtherExpensesAmt
PY Total Expenses$17,253,210PYTotalExpensesAmt
CY Total Expenses$15,345,907CYTotalExpensesAmt
PY Revenues Less Expenses-$12,712,675PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$14,359,230CYRevenuesLessExpensesAmt
Total Assets BOY$82,113,434TotalAssetsBOYAmt
Total Assets EOY$63,522,432TotalAssetsEOYAmt
Total Liabilities BOY$8,156,995TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,651,881TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$73,956,439NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$61,870,551NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO DEVELOPING AND COMMERCIALIZING INNOVATIVE SOLUTIONS FOR SIGNIFICANT UNMET MEDICAL CONDITIONS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$2,171,173ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescAdvanced Technology Projects (New Projects)AMF has several early stage research and development efforts under way in this group that are directed at developing advanced technologies and concepts, including innovative uses for sensors, novel packaging and manufacturing processes for implantable devices including sensors, stimulators and pumps. The team is comprised of research scientists, engineers, legal and intellectual property experts, business strategists and analysts who monitor and evaluate new technologies and new project ideas and concepts before they are elevated to the status of full-fledged development programs. The group also provides business planning support for more mature AMF programs that are on their way to being commercialized. Status:As the projects are in initial feasibility or proof-of-concept stage for the most part, expenditures on any individual project are limited. Successful projects are screened for elevation to development program status, or to be financed in spinout companies by third parties. Unsuccessful efforts are terminated. During the previous period a number of new innovative projects have been evaluated by the team. Several new and promising areas were evaluated and one or more will become formal projects in FY2017.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$3,606,022ExpenseAmt
Grant$3,000GrantAmt
Revenue$23,845RevenueAmt
DescImplantable Myoelectric Sensor (IMES I + Clinical)Initially, the "IMES" project was a consortium project with the following partners: Northwestern University, the Illinois Institute of Technology, and Sigenics (a closely held engineering company). The initial funding for the IMES program was coming from the National Institutes for Biomedical Imaging and Bioengineering (NIBIB) and the National Institute of Child Health and Human Development (NICHD), as well as, the Defense Advanced Research Projects Agency (DARPA). In 2008, AMF assumed control of and responsibility for the entire project, performing mission critical engineering tasks, as well as preparing for and conducting a clinical trial. The IMES system implanted in the residual limb of a limb amputee would transmit muscle signals to the wearable prosthesis to permit control of the prosthesis in a more natural and intuitive manner. Status:AMF has qualified the first generation IMES system for a clinical trial with upper limb amputees. A clinical trial protocol was developed and FDA approval was obtained. Three patients have been implanted at Walter Reed National Military Medical Center ("Walter Reed") and have reported that the new equipment made available to them during the study improved their quality of life. AMF supports this clinical trial directly with frequent on-site visits by AMF personnel, who work in conjunction with physicians and other caregivers at Walter Reed. During 2016 AMF advanced its collaboration with Ossur, a maker of lower-limb prosthetics and other orthotic devices, where two lower limb amputee/patients were implanted with IMES devices. Additionally, AMF entered into a collaboration agreement with Ottobock, the world's largest maker of prosthetic devices (both upper and lower limb), to evaluate IMES devices in connection with a transhumeral (upper limb) amputee, where three patients were implanted with IMES. The Ossur study is being conducted in Iceland, and the Ottobock study is being conducted in Austria, at Europe's largest hospital, Vienna General Hospital, under the auspices of Dr. Oskar Aszmann of the Christian Doppler Laboratory for Restoration of Extremity Function, Medical University of Vienna. The two patients in Iceland and the three patients in Austria are successfully utilizing their devices in accordance with the clinical trial.AMF is in the process of seeking FDA approval of an HDE (Humanitarian Device Exemption) to enable the system to reach its intended patient population. Approval of the submission is anticipated in FY2017.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$4,338,388ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescImplantable Myoelectric Sensor II (Infinity)The initial collaboration was re-vitalized to commence research and development work on a second generation of IMES, (partially supported by a grant from the National Institutes of Health) which will contain advanced features to improve medical outcomes at no additional cost to the patient or healthcare system. Initial design is complete with major focus being on final design and validation activities. Status:The final design of the product is complete and the system is being tested and verified. Peripheral devices that include a telemetry controller module that relays muscle signals to the prosthetic, and a clinician programmer have completed the design phase of the project and a final design review. Production test systems have been validated to prepare for final system verification and validation. Product qualification is in process with completion expected in FY2017.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtGrantGrantAmtRevenueRevenueAmtDescDesc
$2,399,400$5,000$0Sleep Apnea:AMF is investigating the need for newer methods to treat OSA (Obstructed Sleep Apnea). OSA is an under-diagnosed and under-treated medical condition that has been linked to several serious co-morbidities including heart disease. Current treatment options are poorly adopted and when adopted, have low compliance rates. The aim of the AMF program is to develop a neurostimulation product system that will improve medical outcomes at a lower cost than currently available treatment options while solving the compliance issue. Such a product system will consist of a fully implantable neural stimulator sensor, closed loop system with seamless operation requiring minimal interaction from a patient, thereby offering a level of compliance and efficacy favorable to gold standard treatments. Status: A comprehensive product and economic analysis was performed this year demonstrating a need for a tolerable treatment. Several potential designs have been tested and reviewed, which required a number of engineering, animal and cadaver experiments. The process included obtaining input from key opinion leaders; ENT surgeons' implant approaches and pulmonologists treating obstructive sleep apnea. Further testing (both bench and animal) is in process and a final design is anticipated by the end of the fiscal year. Formal product development will begin in FY2017.
$155,263$0$0Neural Respiratory Drive (NRD)Neural respiratory drive (NRD) can be derived from the amount of electrical activity occurring in certain muscles used for breathing. Analysis of electrical activity and other measurements (such as rate of breathing and heart rate) allows early detection of deteriorations in patients with breathing problems so their level of care can be appropriately increased. NRD can be monitored in COPD (Chronic Obstructive Pulmonary Disease) patients as a measure of their physiological effort to breathe. Additional potential applications include asthma and pneumonia sufferers. COPD exacerbations are associated with lung function decline, lower quality of life, and increased mortality. Patients with frequent AECOPD have 4.3 times greater risk of death. Currently used Early Warning Scores designed to identify patients at risk of deterioration are inaccurate and require considerable health care resources. NRD may be used to help patients recognize their symptoms, seek early treatment and prevent exacerbations reach a stage requiring hospitalization. Reduction of severity and prevention of new exacerbations is critical to the wellbeing of COPD sufferers.An NRD monitoring system using the IMES technology would be used to:- Provide an accurate measure of the Neural Respiratory Drive (NRD)- Allow usage in home/acute/office setting- Predict acute exacerbations to prevent hospitalizations- Determine readiness level for hospital discharge- Potentially extend life of COPD patients- Promote patient self-knowledge- Empower patient management of disease- Tie in with consumer devices/cloud storage- Resolve shortcomings of surface electrode EMG recordings- Signal amplitudes calibrated only once due to stability of implanted deviceStatus:The Implanted Myoelectric Sensor (IMES) (Infinity version) will be completed during FY2017. A flat coiled designed interface to the IMES sensor is under development that will power the sensor and provides a data connection for signal analysis and calculation of NRD index. A clinical research system will be developed in FY2017.
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$2,554,663TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$5,000TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$12,670,246TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (1)ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (1)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document34IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee80EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members3GoverningBodyVotingMembersCnt
Independent Voting Member3IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint VentureYes (1)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (1)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1RENEE OLIVIERIBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6617026883PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line125134 RYE CANYON LOOPAddressLine1Txt
CitySANTA CLARITACityNm
State AbbreviationCAStateAbbreviationCd
ZIP91355ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ROBERT GREENBERG
CHAIRMAN2.50Yes (X)Yes (X)$0$0$0
RICHARD WAUGH
BOARD MEMBER2.50Yes (X)$0$0$0
Mari DANIHEL
bOARD MEMBER2.50Yes (X)$0$0$0
BRIAN MANN
BOARD MEMBER0.50Yes (X)$0$0$0
DAVID HANKIN
CEO65.00Yes (X)$469,319$0$33,531
FARAH BOROOMAND
cfo55.00Yes (X)$272,416$0$29,021
MARK CHAMBERLAIN
coo58.00Yes (X)$324,149$0$27,590
JOHN PETROVICH
svp, bus. dev. & general counsel54.00$333,119$0$22,547Yes (X)
MICHAEL PERRIN
VP, QUALITY, regulatory, clinical50.00$183,575$0$21,832Yes (X)
Desmond B Keenan
CTO40.00$179,475$0$9,225Yes (X)
James H Wolfe
PRINCIPAL ASIC DESIGN ENGIneer40.00$173,144$0$27,480Yes (X)
GLEN GRIFFITH
Technical director40.00$218,762$0$21,181Yes (X)
Edward Lee
senior ASIC Design Engineer40.00$175,509$0$22,190Yes (X)
Siegmar Schmidt
Emerging technologies group mgr40.00$171,776$0$15,963Yes (X)
Charles L Byers
principal scientist40.00$189,406$0$15,992Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,690,650TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$246,552TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K36IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Morgan Lewis & Bockius LLP
1701 Market StreetPhiladelphiaPA191032921Legal Services$1,026,482
CDW Direct LLC
PO Box 75723ChicagoIL606755723Hardware/Software$182,294
Ronald C Allen
26637 Durham WayHaywardCA94542Regulatory services$149,427
CMGRP Inc
PO Box 74008263ChicagoIL606748263Marketing services$119,889
computer packages inc
11 n washington street suite 300rockvilleMD20850patent services$106,206
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K10CntrctRcvdGreaterThan100KCnt
All Other Contributions$5,865AllOtherContributionsAmt
Total Contributions$5,865TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
Descresearch grant incomeDesc
Business900099BusinessCd
Total Revenue Column$23,845TotalRevenueColumnAmt
Related Or Exempt Func Income$23,845RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$23,845TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$667,648TotalRevenueColumnAmt
Unrelated Business Revenue$76,035UnrelatedBusinessRevenueAmt
Exclusion$591,613ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$34,144,919SecuritiesAmt
Other$6,600OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$33,862,107SecuritiesAmt
Other$3,093OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$282,812SecuritiesAmt
Other$3,507OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$286,319TotalRevenueColumnAmt
Exclusion$286,319ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
Descother incomeDesc
Business999999BusinessCd
Total Revenue Column$3,000TotalRevenueColumnAmt
Exclusion$3,000ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$3,000OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$986,677TotalRevenueColumnAmt
Related Or Exempt Func Income$23,845RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$76,035UnrelatedBusinessRevenueAmt
Exclusion$880,932ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$8,000TotalAmt
Program Services$8,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,918,033TotalAmt
Program Services$1,409,882ProgramServicesAmt
Management And General$508,151ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$6,198,223TotalAmt
Program Services$5,681,271ProgramServicesAmt
Management And General$516,952ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$115,767TotalAmt
Program Services$105,385ProgramServicesAmt
Management And General$10,382ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$789,103TotalAmt
Program Services$707,631ProgramServicesAmt
Management And General$81,472ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$575,569TotalAmt
Program Services$500,495ProgramServicesAmt
Management And General$75,074ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$1,344,948TotalAmt
Program Services$879,378ProgramServicesAmt
Management And General$465,570ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$85,737TotalAmt
Management And General$85,737ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$229,607TotalAmt
Management And General$229,607ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$939,886TotalAmt
Program Services$832,399ProgramServicesAmt
Management And General$107,487ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$1,172,489TotalAmt
Program Services$1,089,514ProgramServicesAmt
Management And General$81,497ManagementAndGeneralAmt
Fundraising$1,478FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$285,432TotalAmt
Program Services$237,143ProgramServicesAmt
Management And General$48,289ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$855,417TotalAmt
Program Services$731,014ProgramServicesAmt
Management And General$124,403ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$109,065TotalAmt
Program Services$86,182ProgramServicesAmt
Management And General$22,883ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$23,932TotalAmt
Program Services$15,914ProgramServicesAmt
Management And General$8,018ManagementAndGeneralAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$145,588TotalAmt
Management And General$145,588ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$392,399TotalAmt
Program Services$264,432ProgramServicesAmt
Management And General$127,401ManagementAndGeneralAmt
Fundraising$566FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$95,655TotalAmt
Program Services$81,707ProgramServicesAmt
Management And General$13,948ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
Education & Morale$40,615$34,619$5,996
Miscellaneous$20,442$5,280$15,162

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$15,345,907TotalAmt
Program Services$12,670,246ProgramServicesAmt
Management And General$2,673,617ManagementAndGeneralAmt
Fundraising$2,044FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,430,225BOYAmt
EOY$1,392,667EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,335,933BOYAmt
EOY$1,342,188EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$78,448BOYAmt
EOY$68,319EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$323,181BOYAmt
EOY$397,189EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$9,014,816LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$7,480,863LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,474,588BOYAmt
EOY$1,533,953EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$44,957,810BOYAmt
EOY$18,340,481EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$31,674,112BOYAmt
EOY$38,540,950EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$736,306BOYAmt
EOY$694,046EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$102,831BOYAmt
EOY$1,212,639EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$82,113,434BOYAmt
EOY$63,522,432EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,777,475BOYAmt
EOY$1,651,881EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$6,379,520BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$8,156,995BOYAmt
EOY$1,651,881EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$73,956,439BOYAmt
EOY$61,870,551EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$73,956,439BOYAmt
EOY$61,870,551EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$82,113,434BOYAmt
EOY$63,522,432EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$14,359,230ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$2,273,342NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp (2 entries)

CityCityNmState AbbreviationStateAbbreviationCd
WALTER REED NATIONAL MILITARY MEDICAL CENTER
BETHESDAMD
UCLA Foundation
Los AngelesCA

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,608,883OtherCostOrOtherBasisAmt
Depreciation$665,735DepreciationAmt
Book Value$943,148BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,106,633OtherCostOrOtherBasisAmt
Depreciation$4,574,955DepreciationAmt
Book Value$531,678BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,299,300OtherCostOrOtherBasisAmt
Depreciation$2,240,173DepreciationAmt
Book Value$59,127BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,533,953TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (5 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
limited partnerships$819,298F
bioness inc.$2,077,000F
MEDALLION THERAPEUTICS, INC.$25,968,876F
MONOLYTHIX, inc.$4,123,416F
Axonics Modulation Technologies, Inc.$5,552,360F
FieldValueIRS element (for citing)
Total Book Value Securities$38,540,950TotalBookValueSecuritiesAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart X, Line 2:FormAndLineReferenceDesc
ExplanationThe Foundation, under the provisions of ASC 740, Income Taxes, had no uncertain tax positions requiring accrual as of March 31, 2017 and 2016.ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
CENTRAL AMERICA AND THE CARIBBEAN00INVESTMENTS$6,847,602
cENTRAL AMERICA AND THE CARIBBEAN00INVESTMENT FEE EXPENDITURES$81,375
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$6,928,977SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$6,928,977TotalSpentAmt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp OwnershipYes (1)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (1)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (1)ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart I, line 3:FormAndLineReferenceDesc
ExplanationTHE ACCRUAL METHOD OF ACCOUNTING IS USED FOR BOTH AMOUNTS REPORTED AS INVESTMENTS AND EXPENDITURES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
DAVID HANKIN
CEO$342,319$0$115,000$0$12,000$0$5,299$0$28,232$0$502,850$0$0$0
FARAH BOROOMAND
cfo$217,416$0$55,000$0$0$0$4,839$0$24,182$0$301,437$0$0$0
MARK CHAMBERLAIN
coo$274,149$0$50,000$0$0$0$5,299$0$22,291$0$351,739$0$0$0
JOHN PETROVICH
svp, bus. dev. & general counsel$258,119$0$75,000$0$0$0$5,299$0$17,248$0$355,666$0$0$0
MICHAEL PERRIN
VP, QUALITY, regulatory, clinical$161,075$0$22,500$0$0$0$3,415$0$18,417$0$205,407$0$0$0
Desmond B Keenan
CTO$144,475$0$35,000$0$0$0$3,200$0$6,025$0$188,700$0$0$0
James H Wolfe
PRINCIPAL ASIC DESIGN ENGIneer$173,144$0$0$0$0$0$3,633$0$23,847$0$200,624$0$0$0
GLEN GRIFFITH
Technical director$206,262$0$12,500$0$0$0$4,390$0$16,791$0$239,943$0$0$0
Edward Lee
senior ASIC Design Engineer$175,509$0$0$0$0$0$3,598$0$18,592$0$197,699$0$0$0
Siegmar Schmidt
Emerging technologies group mgr$161,776$0$10,000$0$0$0$3,448$0$12,515$0$187,739$0$0$0
Charles L Byers
principal scientist$188,406$0$1,000$0$0$0$3,530$0$12,462$0$205,398$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart I, Line 7FormAndLineReferenceDesc
ExplanationBONUS PAYMENTS WERE MADE, BUT ARE BASED ON ACHIEVEMENTS, GOALS, AND ARE APPROVED BY BOARD OF DIRECTORS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section A, line 6The foundation's articles of incorporation provide that the foundation is a membership corporation, with the members having the rights of membership as described in the foundation's bylaws. The bylaws provided for the foundation to have a lead member, designated by the bylaws to be Alfred E. Mann, who would possess all powers of membership conferred by law. The bylaws also provided that up to four additional members, appointed by the lead member, would have only those rights conferred upon them by the bylaws, which include only the right to name a successor lead member under certain described circumstances. Alfred E. Mann passed away on February 25, 2016, without having appointed any of the four authorized additional members; Mr. Mann's successor(s), if any, have not yet been finally determined.
Form 990, Part VI, Section A, line 7aThe foundation's bylaws provide that the foundation shall have one lead member who has the power to appoint, remove, and name successors for all members of the board of directors of the foundation. Alfred E. Mann passed away on February 25,2016; Mr. Mann's successor(s), if any, have not yet been finally determined. Board members appointed by Mr. Mann continue to serve.
Form 990, Part VI, Section B, line 11bA DRAFT OF FORM 990 WAS PRESENTED BY MANAGEMENT TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW AND DISCUSSION. A FULL COPY OF THE FORM WAS PROVIDED TO ALL VOTING MEMBERS PRIOR TO FILING WITH THE IRS.
Form 990, Part VI, Section B, line 12cCONFLICT OF INTEREST DISCLOSURES ARE UPDATED ANNUALLY AND POTENTIAL CONFLICTS ARE REVIEWED PRIOR TO PARTICIPATING IN TRANSACTIONS. IF A CONFLICT EXISTS, THE PERSON WITH A CONFLICT DOES NOT VOTE.
Form 990, Part VI, Section B, line 15THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE COMPENSATION OF THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO. THEY ALSO REVIEW AND APPROVE THE OVERALL ANNUAL ADJUSTMENTS TO COMPENSATION OF OTHER EMPLOYEES. SPECIFIC ADJUSTMENTS FOR OTHER EMPLOYEES ARE HANDLED BY THE CEO AND HEAD OF HUMAN RESOURCES USING COMPARISONS TO SALARY SURVEYS FOR SIMILAR POSITIONS AND EXPERIENCE. THE BOARD OF DIRECTORS APPROVED COMPENSATION FOR THE CEO AND HIS DIRECT REPORTS INCLUDING THE CFO ON 06/07/17. THIS PROCESS WAS DOCUMENTED.
Form 990, Part VI, Section C, line 19MEMBERS OF THE PUBLIC OR INTERESTED PARTIES MAY REQUEST TO REVIEW OR RECIEVE A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE OR MAIL.

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
Monolythix Inc
4720 calle cargacamarilloCA93012464616473Monolithic structure dvlpm for DNA purify, disease detection, blood analysisNVALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCHC-$967,789$64,2030.67250Yes (1)
Medallion Therapeutics Inc
28575 livingston avenueValenciaCA91355464651082Development and commercialization of medical device (implantable drug pump)DEALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCHC-$6,157,848$6,752,5150.97630Yes (1)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsYes (1)ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth OrgYes (1)RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (3 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
medallion therapeutics inc
D$7,073,683Loan
MEdallion therapeutics inc
A$73,674INTEREST INCOME
MONOlythix inc
D$202,361Loan